# Stent: Evolution

Source page: https://www.materialinsights.org/products/p_stent/prod-evolution/

#### Timeline

The milestones of the product, each with a source

| Year | Event |
|---|---|
| 1977 | Andreas Gruntzig performs the first percutaneous coronary intervention, with a balloon, in September ^[2] |
| 1986 | Jacques Puel, in France, and Ulrich Sigwart introduce metallic coronary stents into clinical practice; Puel's first stent goes in in March ^[2]^[8] |
| 1993 | The FDA approves Cook's Gianturco-Roubin coronary stent, already marketed in Australia, Korea and Singapore ^[6]^[22] |
| 1994 | The FDA approves the Palmaz-Schatz stent and J&J launches it in the United States ^[8]^[7] |
| 1999 | The first drug-eluting stent is implanted ^[7] |
| 2003 | The Cypher is the first drug-eluting stent approved by the FDA ^[8] |
| 2011 | Abbott's Absorb bioresorbable scaffold receives a CE mark in January ^[7] |
| 2016 | The FDA approves the Absorb in July ^[7] |
| 2017 | India's NPPA caps coronary stent prices under notification S.O. 412(E) of 13 February ^[11] |

as of 2026-11-13

#### Lineage

The products and technologies it evolved from and into
 Evolved from

- [Stn Coronary stent](https://www.materialinsights.org/technologies/coronary_stent/) The twin technology page holds the working principle and history; this node covers the stent as goods.

as of 2026-11-13

#### Recipe changes

How what it is made of changed over time, and what drove each change

| Change | From | To | Driver | Source |
|---|---|---|---|---|
| Metal platform and strut thickness | Stainless steel with struts of 130 to 150 µm | Cobalt-chromium and platinum-chromium alloys with struts of 50 to 90 µm | Thinner struts reduced vascular damage while keeping radial strength ^[6]^[2] | ^[6]^[2] |
| Drug coating | Durable polymer carriers | Biodegradable polymer coatings made from lactic or glycolic acids, which dissolve once the drug is released, in some designs | The sources opened name no single reason ^[2] | ^[2] |
| Bare metal to drug-eluting | Bare metal stents | Drug-eluting stents, which at first shared the stainless-steel backbone of bare metal ones (approved in the early 2000s) | A drug on the stent to deal with re-narrowing ^[5] | ^[5] |
| Permanent metal to dissolving scaffold | Permanent metal stents | Bioresorbable scaffolds such as the Absorb, with thick struts (150 µm against 81 µm for the Xience) | Scaffold made to dissolve; development was reported to have failed to achieve further clinical benefits ^[6]^[5] | ^[6]^[5] |

as of 2026-11-13

#### What could improve it next

Directions for improvement, today's value and the limit

| Direction | Metric | Today | Unit | Source |
|---|---|---|---|---|
| Thinner struts in drug-eluting stents | Strut thickness of the Xience cobalt-chromium stent | 81 | µm | ^[6] |
| Zinc and magnesium dissolving scaffolds under study | Strut thickness of the Absorb scaffold, the dissolving design to improve on | 150 | µm | ^[6]^[5] |

as of 2026-11-13

#### Sources

1. [State of the art: coronary artery stents – past, present and future](https://eurointervention.pcronline.com/article/state-of-the-art-coronary-artery-stents-past-present-and-future/pdf) EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
2. [Modern Stents: Where Are We Going?](https://rmmj.org.il/issues/45/1080/manuscript) Rambam Maimonides Medical Journal (Kobo and others), 2020, RMMJ 2020;11(2):e0017, DOI 10.5041/RMMJ.10403
3. [Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry](https://scielo.isciii.es/pdf/recic/v6n4/en_2604-7306-recic-6-4-321.pdf) REC: Interventional Cardiology 6(4):321-331 (Macaya-Ten, Gonzalo, Escaned, Macaya), 2024
4. [The Surprising History Behind an Extremely Common Cardiovascular Medical Device](https://www.mddionline.com/cardiovascular/the-surprising-history-behind-an-extremely-common-cardiovascular-medical-device) MD+DI, no byline or date shown on the page
5. [Stents at 25 years: A revolution in revascularization](https://www.healio.com/news/cardiology/20120331/stents-at-25-years-a-revolution-in-revascularization) Healio (Cardiology Today, Brian Ellis), 2011, dated April 01, 2011
6. [Lok Sabha Unstarred Question No. 2781, Guidelines by NPPA, answered 13 March 2018](https://eparlib.nic.in/bitstream/123456789/771833/1/AU2781.pdf) Lok Sabha, Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), 2018
7. [Cook's Gianturco-Roubin Flex-Stent is first coronary stent approved by FDA (title from the page address; the page text shows no headline)](https://medtech.pharmaintelligence.informa.com/MT000706/COOKS-GIANTURCOROUBIN-FLEXSTENT-IS-FIRST-CORONARY-STENT-APPROVED-BY-FDA-DISTRIBUTION-TO-BEGIN-AFTER) The Gray Sheet, on Medtech Insight (Informa), no date shown; the text gives the FDA panel of May 1992 and approval on 'May 28', which REC (2024) places in 1993

## Other sections

- [Summary](https://www.materialinsights.org/products/p_stent/index.md)
- [Working](https://www.materialinsights.org/products/p_stent/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_stent/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_stent/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_stent/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_stent/prod-footprint/index.md)
- [Interventions](https://www.materialinsights.org/products/p_stent/prod-interventions/index.md)
